The American Cancer Society has recently updated its guidelines for lung cancer screenings, expanding the criteria to include nearly 5 million more adults who smoke or used to smoke. The new guidelines recommend annual lung cancer screenings for individuals aged 50 to 80 years old who have a 20-year or greater pack-year history. This is a significant change from the previous guidelines, which recommended screenings for individuals aged 55 to 74 who currently smoke or had quit within the past 15 years. The update is expected to increase the number of eligible patients by about 37%. However, insurance coverage for lung cancer screenings based on this updated guideline may vary.
In other health news, recent medical studies and trials have highlighted the effectiveness of Selpercatinib vs Chemotherapy in treating RET Fusion–Positive NSCLC and the use of Bispecific T-Cell Engager Tarlatamab in treating Small Cell Lung Cancer. Additionally, a novel blood test for early cancer detection is showing potential, and crowdfunding campaigns are playing a significant role in covering medical expenses for cancer survivors. Furthermore, a drop in E-Cigarette use among High School Students has been observed, and the impact of air pollution on breast cancer risk is being studied.